AZN vs MHH · P/E 28, $288.38B cap vs P/E 43, rev $41.4M
AstraZeneca PLC (AZN) versus Mastech Holdings Inc (MHH) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Mastech Holdings Inc (MHH) is a staffing & employment services company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported MHH revenue for 2026-06-30 was $41.4M. Net income was -$100.0K. Revenue was up 0.9% from 2026-03-31 to 2026-06-30. MHH currently screens at market cap $85.8M and trailing P/E 42.9.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. MHH currently screens at market cap $85.8M and trailing P/E 42.9.
Not investment advice. Open the AZN and MHH stock pages for the full models.
Not investment advice.